Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb 3;3(1):e1009728.
doi: 10.1080/23723556.2015.1009728. eCollection 2016 Jan.

Regulation of hematopoietic progenitors by estrogens as a basis for new antileukemic strategies

Affiliations

Regulation of hematopoietic progenitors by estrogens as a basis for new antileukemic strategies

Abel Sánchez-Aguilera et al. Mol Cell Oncol. .

Abstract

We recently reported that estrogens regulate survival, proliferation, and self-renewal of hematopoietic stem cells and progenitors via estrogen receptor-α activation. Through its proapoptotic effect on malignant progenitors, tamoxifen treatment blocks the development of JAK2 (V617F) -induced myeloproliferative neoplasms in mice and sensitizes MLL-AF9-induced leukemias to chemotherapy, without detrimental effects on normal hematopoiesis.

Keywords: JAK2; MLL-AF9; acute myeloid leukemia; estrogen receptors; estrogens; hematopoietic progenitor cells; hematopoietic stem cells; myeloproliferative neoplasms; selective estrogen receptor modulators; tamoxifen.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Tamoxifen selectively blocks JAK2V617F-induced myeloproliferative neoplasms. Hematologic parameters in peripheral blood of mice transplanted with Mx1-cre;JAK2V617F (top) or wild-type (WT, bottom) cells, treated with tamoxifen (TAM) or vehicle since the onset of thrombocytosis stage (9 weeks after transplantation). Tamoxifen doses (140 or 14 mg/kg, 3 times/week) are indicated. Data are means ± standard deviations. *P < 0.05 (vehicle versus tamoxifen). Both doses of tamoxifen abolish the leukocytosis, thrombocytosis, and reduction in red cell counts associated with progression of the disease. Data shown in this figure represent an extended follow-up of an experiment reported in Sánchez-Aguilera et al.

Similar articles

Cited by

References

    1. Medina KL, Garrett KP, Thompson LF, Rossi MI, Payne KJ, Kincade PW. Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat Immunol 2001; 2:718–24; PMID:11477408; http://dx.doi.org/10.1038/90659 - DOI - PubMed
    1. Illing A, Liu P, Ostermay S, Schilling A, de Haan G, Krust A, Amling M, Chambon P, Schinke T, Tuckermann JP. Estradiol increases hematopoietic stem and progenitor cells independent of its actions on bone. Haematologica 2012; 97:1131–5; PMID:22371175; http://dx.doi.org/10.3324/haematol.2011.052456 - DOI - PMC - PubMed
    1. Sanchez-Aguilera A, Arranz L, Martin-Perez D, Garcia-Garcia A, Stavropoulou V, Kubovcakova L, Isern J, Martin-Salamanca S, Langa X, Skoda RC, et al. . Estrogen signaling selectively induces apoptosis of hematopoietic progenitors and myeloid neoplasms without harming steady-state hematopoiesis. Cell Stem Cell 2014; 15:791–804; PMID:25479752; http://dx.doi.org/10.1016/j.stem.2014.11.002 - DOI - PubMed
    1. Nakada D, Oguro H, Levi BP, Ryan N, Kitano A, Saitoh Y, Takeichi M, Wendt GR, Morrison SJ. Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancy. Nature 2014; 505:555–8; PMID:24451543; http://dx.doi.org/10.1038/nature12932 - DOI - PMC - PubMed
    1. Yakimchuk K, Hasni MS, Guan J, Chao MP, Sander B, Okret S. Inhibition of lymphoma vascularization and dissemination by estrogen receptor β agonists. Blood 2014; 123:2054–61; PMID:24470591; http://dx.doi.org/10.1182/blood-2013-07-517292 - DOI - PubMed

LinkOut - more resources